期刊文献+

^(131)I联合促甲状腺激素抑制治疗对分化型甲状腺癌血生化及骨密度的影响 被引量:9

Effect of combined ^(131)I and TSH suppressive therapy on bone mineral density and blood biochemical indexes in patients with differentiated thyroid carcinoma after surgery
下载PDF
导出
摘要 目的观察术后^(131)I联合促甲状腺激素(TSH)抑制治疗的分化型甲状腺癌(DTC)患者,研究TSH抑制治疗对血生化及骨密度(BMD)的影响。方法选择DTC术后患者44例,均在术后使用^(131)I清除残余甲状腺,"清甲"治疗后及时给予甲状腺素片行TSH抑制治疗,TSH抑制至<0.1 mU/L。"清甲"治疗6个月左右,进行清甲"是否成功的评估"或清灶"治疗。患者2次入院均空腹测定血生化全套,包括谷丙转氨酶(GPT)、谷草转氨酶(GOT)、碱性磷酸酶(AKP)、血糖(GLU)、尿素氮(BUN)、肌酞(Cr)、钙(Ca)、磷(P)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、降钙素(CT)、骨钙素(BGP)、甲状旁腺激素(PTH)、25羟维生素D3(VD3);2次入院均测定腰椎(L_(1-4)、左股骨颈(Neck)、左大转子(Troch)、左沃氏三角区(Ward's)的BMD(g/cm^2)。2次入院数据的差值以△表示,如△GPT-GPT_1-GPT_2。结果①年龄和Ward_1呈负相关,而且年龄和Neck_2、Ward_2负相关更明显,多元回归方程也有一致结果(Ward_2=1.001-0.008);年龄与△Ward呈正相关。②术后时间间隔平均60.5 d,与△BGP呈负相关,与4个部位BMD无显著相关性。③TSH抑制时间与BGP_2呈负相关,与Neck_2呈正相关。结论短期内(6个月左右)^(131)I联合TSH抑制治疗对BMD的影响较小,仅表现为年龄和Ward呈负相关,且越是高龄患者治疗后Ward更低、△Ward越大;术后时间间隔及TSH抑制时间对BMD的影响不显著。 Objective To investigate the effect of thyroid-stimulating hormone(TSH) suppressive therapy on bone mineral density(BMD) and blood biochemical indexes in patients with differentiated thyroid carcinoma(DTC) who had received ^131I after surgery.Methods This study recruited 44 patients with DTC who had received ^131I ablation therapy and were taking LT4 after surgery(TSH 0.1 mU/L).After 6 month of ablation therapy,these patients would be hospitalized again to assess whether therapy was successful or the removal of metastases was needed.The patients' blood biochemical indexes were analyzed when they were hospitalized at the first time and the second time.Those blood biochemical indexes included GPT,GOT,AKP,GLU,BUN,Cr,Ca,P,TC,TG,HDL,LDL,CT,BGP and PTH.Besides,the indexes including the BMD of L1-L4,Neck,greater Troch and Ward's triangle were analyzed.The differences in the values were expressed as A.For example,AGPT = GPT_1-GPT_2.Results A negative correlation was found between age and Ward_1,and the negative correlations of age with Neck_2 and Ward_2 were more obvious.The multiple regression equation also supported those results(Ward_2 = 1.001-0.008 year).Age was positively correlated to ΔWard.The postoperative time interval(at average of 60.5 days) was negatively correlated to ABGP and had no significant correlation with BMD of any part.The TSH suppression time was negatively correlated to BGP2 and positively correlated to Neck2.Conclusions The combination of ^131I and TSH suppressive therapy has little influence on BMD in a duration of 6 months.Age is negatively correlated to Ward.The older the patients,the lower the Ward and the larger the AWard.Neither postoperative time interval nor TSH suppression time has significant effect on BMD.
出处 《中国现代医学杂志》 CAS 北大核心 2016年第2期68-71,共4页 China Journal of Modern Medicine
关键词 ^131I TSH抑制治疗 分化型甲状腺癌 血生化 骨密度 ^131I TSH suppressive therapy DTC blood biochemical index BMD
  • 相关文献

参考文献10

  • 1Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thy- roid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2009, 19(11): 1167- 1214.
  • 2Murphy E, Williams GR. The thyroid and the skeleton[J]. Clini- cal endocrinology, 2004, 61(3): 285-298.
  • 3Karga H, Papapetrou PD, Korakovouni A, et al. Bone mineral density in hyperthyroidism[J]. Clinical Endocrinology, 2004, 61(4): 466-472.
  • 4Ross DS. Hyperthyroidism, thyroid hormone therapy and bone[J]. Thyroid, 1994, 4(3): 319-326.
  • 5Reverter JL, Holgado S, Alonso N, et al. Lack of deleterious ef- fect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma[J]. Endocrine-related cancer, 2005, 12(4): 973-981.
  • 6韦爱青.年龄与血脂的关系及临床意义[J].医学理论与实践,2011,24(22):2688-2689. 被引量:5
  • 7胡小军,匡荣彬.骨代谢标志物在老年骨质疏松症诊疗中的意义[J].中国组织工程研究,2015,19(7):1013-1017. 被引量:26
  • 8Kim MK, Yun KJ, Kim MH, et al. The effects of thyrotropin suppressing therapy on bone metabolism in patients with well differentiated thyroid carcinoma[J]. Bone, 2015, 71: 101-105.
  • 9Fujiyama K, Kiriyama T, Ito M, et al. Suppressive doses of thy- roxine do not accelerate age-related bone loss in late post- menopausal women[J]. Thyroid, 1995, 5(1):13-17.
  • 10Ribot C, Tremollieres F, Pouilles JM, et al. Bone mineral den- sity and thyroid hormone therapy[J]. Clin Endocrinol, 1990, 33(2): 143-154.

二级参考文献23

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 2Assessment of fracture risk and its application to screening for post-menopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129.
  • 3KanisJA, Bianchi G, BilezikianJP,etal.Towards a diagnostic and therapeutic consensus in male osteoporo-sis. Osteoporos Int. 2011 ;22:2.789-98.
  • 4Schuit SC, van der Klift M, WeelAE,etal.Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34:195-202.
  • 5Gallacher SJ, Dixon T.lmpact of treatments for postmenopausal os-teoporosis (Bisphophonates, Parathyroid Hormone, Strontium Ranelate and Denosumab) on bone quality: a systematic review. CalcifTissue Int. 2010;87: 469-684.
  • 6KanisJA,Johnell 0, Oden A,et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385-97.
  • 7Vasikaran S, Eastell R, Bruyere 0, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int.2011 ;22:391-420.
  • 8KanisJA. Diagnosis of osteoporosis and assessment of fracture risk.Lancet.2002, 359: 1929-36.
  • 9Cosman F, Lindsay R, LeBoffMS,et al. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis 2013.
  • 10Rodrigues AM, Caetano-LopesJ, Vale AC,et al. Low osteocalcin/collagen type I bone gerie expression ratio is associ-ated with hip fragility fractures. Bone.2012;51 :981-9.

共引文献29

同被引文献94

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部